U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07069712) titled 'A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma' on June 24.
Brief Summary: GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as perioperative treatment in participants with locally advanced resectable gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma who have not received previous treatment for the disease.
Study Start Date: July 14
Study Type: INTERVENTIONAL
Condition:
Gastroesophageal Adenocarcinoma
I...